SCHEMBL1355489

SCHEMBL1355489

CCNc1cccnc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL10704335 0.98 RAB9A (0.56)
Hydrochloric Acid SCHEMBL28089121 0.98 RAB9A (0.56)
Propionic Acid SCHEMBL28285873 0.88 RAB9A (0.51)
Ethoxycarbonyl Group SCHEMBL28051789 0.83 RAB9A (0.44)
SCHEMBL3643530 0.83 RAB9A (0.54)
SCHEMBL4507702 0.80 LMNA (0.53)
SCHEMBL5216349 0.80 EPHX2 (0.54)
SCHEMBL20729480 0.79 CYP2A6 (0.54)
SCHEMBL215190 0.79 LMNA (0.55)
Pyridine SCHEMBL61964 0.78 LMNA (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 268 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112062756-B Stenhouse donor-acceptor adducts of mevalonate activated furan and 3-pyridylethylamine and methods of synthesizing the same 南京理工大学 2023-07-07 CN claimed
CN-112062756-A Mannhouse donor-acceptor adduct of furan and 3-pyridine ethylamine activated by Merlox acid and synthetic method thereof 南京理工大学 2020-12-11 CN claimed
US-9551018-B2 Process for the preparation of optically active chiral amines LONZA AG (CH) 2017-01-24 US claimed
US-9394297-B2 Amides as pim inhibitors AMGEN INC. (US) 2016-07-19 US claimed
US-20150329538-A1 AMIDES AS PIM INHIBITORS AMGEN INC. (US) 2015-11-19 US claimed
US-20150284752-A1 PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE CHIRAL AMINES LONZA AG (CH) 2015-10-08 US claimed
US-9074228-B2 Process for the preparation of optically active chiral amines LONZA AG (CH) 2015-07-07 US claimed
EP-2202318-A1 Process for the preparation of optically active chiral amines Lonza AG (CH) 2010-06-30 EP claimed
EP-1987152-B1 PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE CHIRAL AMINES LONZA AG (CH) 2010-05-26 EP claimed
US-20090246837-A1 Process for The Preparation of Optically Active Chiral Amines LONZA AG (CH) 2009-10-01 US claimed
EP-1987152-A1 PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE CHIRAL AMINES Lonza AG (CH) 2008-11-05 EP claimed
EP-1897956-A1 Process for preparation of optically active amines by optical resolution of racemic amines employing a bacterial omega-transaminase Lonza AG (CH) 2008-03-12 EP claimed
WO-2007093372-A1 PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE CHIRAL AMINES LONZA AG (CH) 2007-08-23 WO claimed
EP-1818411-A1 Process for the preparation of optically active chiral amines Lonza AG (CH) 2007-08-15 EP claimed
EP-1381607-B1 NOVEL PYRIDINE- AND CYCLOHEXENYL-COMPRISING PYRROLOBENZODIAZEPINE-CARBOXAMIDES AND DERIVATIVES THEREOF; TOCOLYTIC OXYTOCIN RECEPTOR ANTAGONISTS WYETH CORP (US) 2005-10-26 EP claimed
EP-1568770-A2 Pharmaceutical use of compounds which bind to a mammalian \"trace amine\" receptor Oregon Health &amp; Science University (US) 2005-08-31 EP claimed
US-20040072187-A1 Novel mammalian receptor genes and uses OREGON HEALTH & SCIENCE UNIVERSITY 2004-04-15 US claimed
EP-1319070-A2 MAMMALIAN RECEPTOR GENES AND USES Oregon Health &amp; Science University (US) 2003-06-18 EP claimed
WO-2002022801-A2 MAMMALIAN RECEPTOR GENES AND USES OREGON HEALTH & SCIENCE UNIVERSITY (US) 2002-03-21 WO claimed
US-4515708-A BETA-PYRIDYLETHYLAMINE EXXON RESEARCH & ENGINEERING CO. (US) 1985-05-07 US claimed